All News

    Knowledge Isn’t Enough When Action Costs Too Much

    December 11th 2025, 10:00pm

    Article

    I struggle to understand why people support policies and leaders that make healthcare less affordable and accessible for everyone.

    What Does Minimal Residual Disease Mean?

    December 11th 2025, 9:00pm

    Article

    CURE spoke with Dr. Dickran Kazandjian about why MRD matters for patients with multiple myeloma.

    Preoperative Breast MRI Did Not Improve Outcomes in Early-Stage Breast Cancer

    December 11th 2025, 6:46pm

    Article

    The 60-month local regional recurrence-free rate was 93.2% in the MRI arm versus 95.7% in the no MRI arm, researchers reported.

    Enhertu/Perjeta Combo Enhances Quality of in HER2+ Advanced Breast Cancer

    December 11th 2025, 5:51pm

    Article

    Enhertu and Perjeta led to better quality-of-life and less side effects than standard-of-care among patients with HER2+ advanced or metastatic breast.

    Radiation Plus Keytruda Before Surgery Boosts Immune Response in Breast Cancer

    December 11th 2025, 5:43pm

    Article

    Adding radiation before surgery with Keytruda increased immune cells in tumors and led to encouraging responses in people with early-stage breast cancer.

    Checkpoint Inhibitors May Impact Fertility in Early TNBC Treatment

    December 11th 2025, 4:06pm

    Article

    Tecentriq numerically increased the rates of chemotherapy-induced ovarian failure compared with chemotherapy alone for patients with triple-negative breast cancer.

    Verzenio Offers Potential Benefit After Prior Therapy in HR+/HER2– Breast Cancer

    December 11th 2025, 3:36pm

    Article

    Verzenio showed meaningful improvement for some patients with HR-positive, HER2-negative breast cancer after prior CDK4/6 treatment.

    Tukysa Combo Boosts Frontline Maintenance in Advanced HER2+ Breast Cancer

    December 11th 2025, 2:00pm

    Article

    Tukysa added to Herceptin and Perjeta improved progression-free survival versus placebo in HER2-positive metastatic breast cancer after initial therapy.

    From Stage 4 to Survivor: Dan’s Pancreatic Cancer Journey

    December 10th 2025, 10:00pm

    Article

    Dan, diagnosed with stage 4 pancreatic cancer, shares his journey to remission and insights on clinical trials and patient advocacy.

    Momelotinib Combo is Safe and Helps Ease Symptoms in Myelofibrosis

    December 10th 2025, 9:48pm

    Article

    Nuvisertib plus momelotinib is safe and generated improvements in symptom burden, spleen volume, and anemia outcomes in relapsed/refractory myelofibrosis.